ArticleImmunology and cell biology

IRF5 is a novel regulator of CXCL13 expression in breast cancer that regulates CXCR5(+) B- and T-cell trafficking to tumor-conditioned media.

Erica Maria Pimenta et al.PubMed ↗Publisher ↗

No numbers read from the abstract.